# A pharma giant is moving past one patent cliff — but another is already looming

- Source: CNBC Top News
- Published: 2026-10-30T06:00:01+00:00
- Category: Markets
- Original: https://www.cnbc.com/2026/10/30/novartis-remibrutinib-multiple-sclerosis.html
- Canonical: https://groundlevelnews.com/story/a-pharma-giant-is-moving-past-one-patent-cliff-but-another-is-already--e33940/

Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.

_Ground Level News shows a short summary only; the full article and all rights belong to CNBC Top News._